The preten newborn lamb has high concentrations of circulating prostaglandin E2 (PGE2) that may play a role in maintaining the patency of the ductus arteriosus. PGE2 is removed rapidly from the venous circulation by the lung and is metabolized to its 15-keto metabolites by the intracellular enzyme, 15-OH prostaglandin dehydrogenase (15-OHPD). We studied the ability of the isolated, perfused lung from 100 days gestation (n=8) and near term (term is 150 days) lamb fetuses (n=10) to tabolize PGE2. After an intraaterial infusion of 3~-~~~2 and "C-inulin (to act as a marker of extracellular space), the majority of 3~ activity was cleared through the ung after the 14c activity had fallen to negligible values. The ' H activity that was retained longer in the lung was primarily associated with the 15-keto metabolites of PGE2. Lungs from immature fetal lambs metabolized 25% less PGE2 than did lungs from animals near term. 15-OHPD activity in homogenates of lamb lung is not higher near t e n than at 100 days. This suggests that transport processes that regulate the uptake of PGE2 into the intracellular compartment, and not 15-OHPD, may represent the limiting step in the pulmonary clearance of PGE2 in the developing lamb lung. This is consistent with our prior observation that premature lambs have decreased plasma clearance rates (in vivo) and elevated circulating concentrations of PGE2 when compared with term newborn lambs.
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PDA WITH SURFACTANT REPLACEMENT THERAPY Ronald I.
Med. Ctr., SF and Harbor-UCLA, Torrance
Surfactant instillation into the trachea of preterm infants with RDS is associated with a 90% incidence of PDA. We studied the effects of surfactant therapy on the ductus arteriosus (DA) in 12 preten lambs (.89 gestation). Flow (Q) across the DA and systemic blood flow were calculated from microsphere injections.
1
All 12 lambs were paralyzed and ventilated with 100% 02. All developed respiratory failure (pH<7.1, PC0>60) by 30 min after birth. Between 30-60 mins after birth, 6 lambs were treated , with tracheal instillation of 50 mg/kg surfactant lipid (purified from alveolar washes from adult sheep). There were no significant differences between control and treated animals prior to surfactant instillation for PC02, pH, prostaglandin (PG) E2 concentrations, the ratio of L 3 R shunt through the DA vs systemic flow (Q shunt19 syst), DA resistance, or the ratio of pulmonary to systemic vascular resistance (RPIRS). By 2 hr after birth treated lambs differed significantly from controls in pH (7.275.02 vs 6.975.08) and PC02 (43.354.1 vs 8555). There were no differences in PO2 (146550 vs 84+44), PGE2 concentrations or DA resistance. However, there was a significantly larger shunt through the DA in treated lambs (Q shunt/syst=. 7%. 14 vs .25210). This increased DA shunt was due to the significant drop in pulmonary vascular resistance (RP/RS=.47+.08 vs .76+.08) and not to a change in patency of the DA. Surfactant replacement may require interventions directed at the PDA to adequately treated sick preterm infants. Using a flow-through collection system and a reduction gas detector (res.= 1 ppb C012.5 ml sample), we made paired measurements of Veto and COHb in 32 terms (38-42 wks) and 24 prematures (28-36 wks) breathing room air in the first week of life. The terms included babies with a wide range of endogenous CO production rates (VCo). For an individual baby, Veto was repeatable with an error of k 8% of the mean Veto over 3-4 hrs despite changes in room air CO (RACO). Based on the line (COHb=.16 RACO+ .53; r=.59; n=56; p < .0005), we corrected COHb for each baby . Using COHb,, we found that COHbc=. 021
RELATIONSHIP OF THE PULMONARY EXCRETION RATE OF CO

(VeCO) AND THE BLOOD CARBOXYHEMOGLOBIN LEVEL (COH~)
VeC0+.19 (r=.71; n=56; p < ,0005). When prematures were analyzed alone, the line (COHbc=.017 VeC0+.30) was less significant (r= .43; p < .05) compared to that (COHbc=.024 VeC +.13; r=.75; p < .0005) of terms. A correction for terms alone q.17) did not alter their line; for prematures alone (.097), a 40% increase in the intercept resulted from babies with a high COHb and a low Veto. These data suggest that in the steady state la) Veto reflects VCO and is not affected by RAC0, lb) COHb reflects both VCO and RACO and requires correction for RAco, 2) Veto and COHbc are correlated over a wide range of VCO in prematures and terms, and 3) a paired high COHb and low VeCO may reflect problems of ventilation and perfusion or shunt which occur in prematures. Using a flow-through collection system and a highly sensitive (1 ppb CO per 2.5 ml sample) reduction gas detector, we measured Veto and COHb (1-2 h whole blood) in 20 normal terms (38-42 wks) and 23 prematures (28-36 wks) breathing room air in the first week of life. The mean Veto (16.7k5.0 pl/kg/hr) of the prematures was greater than that (13.9k3.5 pl/kg/hr) of the normal terms (p < .05). Veto varied among the prematures (range 5.6 to 28.1 pl/kg/hr) and &s not related simply to gestational age. Based on a linear relationship between room air CO (RACO) and COHb (p < .0005), each infant's COHb was corrected (COHbc) for RACO (.36 -3.10 ppm). The mean COHbc (.58f.18% sat.) of prematures (range .29-1.19%) was greater than that (.45+.11% sat.; n.15) of normal terms (p < ,025). The 8 prematures who required phototherapy had higher Veto (19.5c5.5 vs 15.1k4.1 pl/kg/hr; p < .05) and higher COHbc (.71+.21 vs.51+.12% sat.; p <.01) means compared to those of the prematures who did not. These data suggest that 1) prematures have a wide range of CO production rates, 2) this range is not the result of known hemolytic disease or related simply to gestational age, and 3) other factors associated with prematurity but variable among individual prematures may be contributing to increased CO production rates in certain infants. n) were admi.tted to the Stanford Intensive Care Nursery. Of these, 144 (63%) died at < 28 days of age; there were 11 late deaths, including 4 postdischarge. The overall mortality was 68%. Of 74 survivors, 60 with a mean BW of 928k67 (S.D.) gm were followed for 3 years. Thirty-eight % of those followed had a history of mechanical ventilation; none requiring this prior to 1967 survived. Psychometric testing of 48 children at 3 years of age resulted in a mean IQ of 92k20 (S.D.); using matched-pair analysis, the mean IQ 90+20 (S.D.), of 28 children was not different from that, 96k18 (S.D.), of their siblings. Seventy-two % of all survivors followed were completely normal at 3 years of age. Of 17 with late morbidity, 10 have moderate handicaps (IQ 60-80, neuromuscular disability requiring physical or orthopedic therapy but not compromising functional independence, or remediable visual or hearing deficits), and 7 have severe handicaps (IQ < 60, neuromuscular disability compromising functional independence, blindness, or deafness). From 1977-79, the mean yearly admission rate of VLBW infants was > 2-fold that from 1961-76; this fact was associated with a 76% (75/99) .overall survival which was > that, 32% (74/229), prior to 1977 (p < .001). Our improved survival rate for more infants yearly and our low incidence of severe late morbidity (12%) are encouraging results of intensive care for VLBW infants. To determine the magnitude o f the risks in TPN delivered via peripheral vein, the incidence o f adverse reactions to TPN was evaluated as a part of on-going prospective study on neonatal adverse drug reactions. Data o n 456 neonates admitted to the Neonatal Intensive Care Unit were analyzed. O f these, 105 babies (23%) had TPN(glucose, amigen, intralipid) for 3024 days with a mean TPN duration o f 28.3 days per patient (range 1-174 d). TPN was started at age 5.1 d (range 1-48) for GI abnormalities (33.3%,e.g. necrotizing enterocolitis omphalocoele), severe prematurity (13.3%) and respiratory disorders (39.0%). 96 neonates survived (91.4%). 7 had a total of 9 central vennus lines. The average weight gain per day was 8.36 g (range-35 t o 30.5 g). Hyperglycemia (>I50 mg/dl, peak 695 mg/dl) occurred in 28 babies (26.7%), glycosuria i n 19.0% and sjgnificant lipidemia i n 18.1%. Abnormal liver function tests and liver disease were noted in 20 babies (19.0%); due to cytomeqalovirus in one with no definitive cause in the others. 324 skin necrosis or sloughs (>0.5 cm) occurred i n 71 babies (67.6%) while o n TPN. 2 neonates developed severe trace metal deficiency, 1 died. Data underscore need for close surveillance and improvement of TPN techniques in the neonate.
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